Literature DB >> 3728823

Routine colonoscopy in the management of colorectal carcinoma.

C A Weber, K E Deveney, C A Pellegrini, L W Way.   

Abstract

A prospective study of the role of preoperative and routine follow-up colonoscopy in 75 patients with colon and rectal carcinoma disclosed that additional premalignant or malignant lesions were detected and successfully treated in 44 percent of patients. These included four synchronous and three metachronous carcinomas. Timely diagnosis and treatment of such tumors and secondary prevention of metachronous carcinomas by polypectomy is a major identifiable benefit of close follow-up examinations of these patients. No other test compares favorably with colonoscopy in this regard. These data support the conclusion that colonoscopy should be performed routinely preoperatively and every 6 to 12 months after colectomy for carcinoma.

Entities:  

Mesh:

Year:  1986        PMID: 3728823     DOI: 10.1016/0002-9610(86)90150-9

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  4 in total

1.  Conceptual developments through colonoscopy.

Authors:  T R Schrock
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

2.  Six-year results of annual colonoscopy after resection of colorectal cancer.

Authors:  G Juhl; G M Larson; R Mullins; S Bond; H C Polk
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

3.  Follow-up in colorectal cancer patients: a cost-benefit analysis.

Authors:  R A Audisio; P Setti-Carraro; M Segala; D Capko; B Andreoni; G Tiberio
Journal:  Ann Surg Oncol       Date:  1996-07       Impact factor: 5.344

Review 4.  Early detection of colorectal cancer recurrence in patients undergoing surgery with curative intent: current status and challenges.

Authors:  Patrick E Young; Craig M Womeldorph; Eric K Johnson; Justin A Maykel; Bjorn Brucher; Alex Stojadinovic; Itzhak Avital; Aviram Nissan; Scott R Steele
Journal:  J Cancer       Date:  2014-03-15       Impact factor: 4.207

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.